-
Mashup Score: 0
Elizabeth Gasser also discusses the company’s recent acquisition of AMF Medical as well as how it factors environmental impact into device design.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
A new study highlighted that patients with diabetes enrolled in Medicare Advantage (MA) had better outcomes compared with patients in traditional fee-for-service (FFS) Medicare.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Patients with #type2 #diabetes had better outcomes when enrolled in Medicare Advantage (MA) compared to traditional fee-for-service (FFS) Medicare. Read More: https://t.co/ncaYOBlPWu https://t.co/vgb3pcetFD
-
-
Mashup Score: 3Artificial Pancreas Developed That Can Help Maintain Healthy Glucose Levels in Type 2 Diabetes Patients - 1 year(s) ago
Artificial Pancreas Successfully Trialed for Use by Type 2 Diabetes Patients Scientists at the University of Cambridge have successfully trialed an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – do
Source: SciTechDailyCategories: Healthcare Professionals, Latest HeadlinesTweet-
Artificial #Pancreas Developed That Can Help Maintain Healthy #Glucose Levels in #Type2 #Diabetes Patients #type2diabetes #HealthTech #CGM @EvanKirstel @eViRaHealth https://t.co/Vwx9uRDHQR
-
-
Mashup Score: 0Diabetes Medications Linked to Multiple Sclerosis: New Study Uncovers Surprising Connection - 1 year(s) ago
The University of Arizona Center for Innovation in Brain Science conducted a study to investigate whether taking medication for Type 2 diabetes increases the likelihood of developing multiple sclerosis. According to a study from the University of Arizona Health Sciences, people over the age of 45
Source: SciTechDailyCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Diabetes Medications Linked to #MultipleSclerosis: New Study Uncovers Surprising Connection #type2 #type2diabetes #metabolicsyndrome @eViRaHealth https://t.co/v34U2WZj1P
-
-
Mashup Score: 0Partial suppression of type 2 inflammation with mepolizumab - 1 year(s) ago
We read with interest the results of the MAPLE trial showing additional suppression by prednisolone of FeNO, blood, and sputum eosinophils in patients taking mepolizumab.1 These findings illustrate the limited impact of mepolizumab on type 2 inflammation with regard to persistent IL4/IL13 escape in the presence of IL5 blockade.2 As such, this reinforces the importance of carefully observing type…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! #Partial #suppression of #type2 #inflammation with #mepolizumab https://t.co/KT54XB5Dl8
-
-
Mashup Score: 8
A new study suggests metformin use in patients with type 2 diabetes could reduce the risk of joint replacement resulting from “osteoarthritis.”
Source: interestingengineering.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @CurieuxExplorer: #Metformin could lower the risk of joint replacement in #type2 #diabetes patients https://t.co/7h57T1FAwg @Healthcar…
-
-
Mashup Score: 0Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical | Medgadget - 1 year(s) ago
Bigfoot Biomedical, a medtech company based in California, has developed the Bigfoot Unity System, a diabetes management technology for patients on multiple daily injection therapy. The system uses continuous glucose monitoring data and doctor recommendations to provide insulin dose recommendations, helping patients to avoid uncertainty. The company argues that type 2 diabetes patients have…
Source: www.medgadget.comCategories: Future of Medicine, Latest HeadlinesTweet-
#Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical https://t.co/qU3LulBhCV #Bigfootbiomed #Type2 #Exclusive #Medicine #Telemedicine https://t.co/e6YoMqTZYz
-
-
Mashup Score: 0
Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
Friday Q&A: @embecta CEO talks @BDandCo #spinoff, future of #diabetes devices - Dev Kurdikar spoke with @MedTechDive about developing an #insulinpump for patients with #Type2 diabetes and what’s next for the firm. https://t.co/UkbPyywstf
-
-
Mashup Score: 0Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype - 1 year(s) ago
The Global Initiative for Asthma report recommends consideration of add-on biologics for patients with type 2 inflammation (blood eosinophils ≥150 cells/μL, fractional exhaled nitric oxide [Feno] ≥20 parts per billion or allergic asthma) whose asthma cannot be controlled by high-dose inhaled corticosteroids. In QUEST (NCT02414854), add-on dupilumab versus placebo was efficacious in patients with…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Dupilumab Is #Effective in #Patients With #Moderate-to- #Severe Uncontrolled #GINA-Defined #Type2 #Asthma #Irrespective of an #Allergic #Asthma #Phenotype https://t.co/n4pwHBWEMP https://t.co/kP0B1hvWov
-
-
Mashup Score: 0
Ochsner Health Chief Digital Officer Dr. Denise Basow discusses the health system’s remote monitoring pilot program for Medicaid patients with chronic conditions like hypertension and Type 2 diabetes.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
Ensuring #digitalhealth programs work for #Medicaid population - @OchsnerHealth Chief Digital Officer Dr. Denise Basow discusses health sys's #RPM pilot program for Medicaid patients with #chronicdisease conditions like #hypertension & #Type2 #diabetes https://t.co/u0Sd3Zs0NX
-
Friday Q&A: @TandemDiabetes chief strategy officer talks tubeless #insulinpumps, #Type2 plans | #diabetes https://t.co/TTWxEZpG37